Response to Intermediate stage treatment: Is TACE enough?

Liver Int. 2018 Jan;38(1):188-189. doi: 10.1111/liv.13624.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Chemoembolization, Therapeutic*
  • Humans
  • Liver Neoplasms
  • Treatment Outcome